GAVIOLI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 12.511
AS - Asia 5.496
EU - Europa 3.934
SA - Sud America 846
AF - Africa 92
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.888
Nazione #
US - Stati Uniti d'America 12.271
SG - Singapore 2.350
CN - Cina 1.571
PL - Polonia 758
BR - Brasile 729
UA - Ucraina 677
DE - Germania 595
IT - Italia 580
HK - Hong Kong 492
GB - Regno Unito 415
TR - Turchia 384
VN - Vietnam 338
FI - Finlandia 217
SE - Svezia 217
RU - Federazione Russa 143
CA - Canada 115
FR - Francia 96
MX - Messico 95
IN - India 75
BE - Belgio 70
ID - Indonesia 69
AR - Argentina 58
NL - Olanda 52
ZA - Sudafrica 42
JP - Giappone 41
BD - Bangladesh 37
IQ - Iraq 27
ES - Italia 25
LT - Lituania 25
IR - Iran 17
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
MA - Marocco 14
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
AT - Austria 11
CO - Colombia 11
PY - Paraguay 10
KE - Kenya 9
PK - Pakistan 9
CL - Cile 8
EC - Ecuador 7
IE - Irlanda 7
JM - Giamaica 7
RO - Romania 7
TN - Tunisia 7
OM - Oman 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
AU - Australia 5
EG - Egitto 5
IL - Israele 5
JO - Giordania 5
KR - Corea 5
PA - Panama 5
PE - Perù 5
AL - Albania 4
CH - Svizzera 4
DZ - Algeria 4
KZ - Kazakistan 4
SN - Senegal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
MY - Malesia 3
RS - Serbia 3
GE - Georgia 2
HN - Honduras 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 22.884
Città #
Singapore 1.387
Fairfield 1.283
Ashburn 1.235
Woodbridge 1.108
Houston 894
Warsaw 750
Jacksonville 729
Ann Arbor 726
Chandler 684
Beijing 541
Santa Clara 536
Seattle 515
Hong Kong 491
Wilmington 456
Cambridge 439
Dallas 283
Los Angeles 232
Ferrara 230
Izmir 230
Nanjing 181
New York 176
Munich 154
Princeton 149
San Diego 144
Ho Chi Minh City 115
Boardman 107
Milan 94
Shanghai 89
São Paulo 81
Hanoi 80
The Dalles 71
Brussels 70
Mexico City 68
Shenyang 68
Buffalo 62
Hefei 62
Nanchang 56
Turku 50
Dearborn 49
London 48
Montreal 46
Tianjin 46
Addison 45
Jakarta 45
San Mateo 45
Bologna 44
Hebei 42
Chicago 41
Tokyo 41
Changsha 40
Bremen 38
Jinan 37
Falls Church 36
Brooklyn 35
Helsinki 35
Boston 34
Jiaxing 31
Chennai 29
San Francisco 29
Stockholm 29
Phoenix 28
Mountain View 27
Council Bluffs 26
Orem 25
Toronto 25
Atlanta 23
Dong Ket 23
Falkenstein 23
Frankfurt am Main 23
Poplar 23
San Jose 22
Auburn Hills 21
Moscow 21
Amsterdam 20
Denver 20
Johannesburg 20
Rio de Janeiro 20
Belo Horizonte 19
Haiphong 18
Manchester 18
Zhengzhou 18
Ningbo 17
Norwalk 17
Ardabil 16
Columbus 16
Des Moines 16
Modena 16
Redwood City 16
Rome 16
Guangzhou 15
Porto Alegre 15
Tashkent 15
Ankara 14
Brasília 14
Da Nang 14
Tappahannock 14
Kunming 13
Ottawa 13
Philadelphia 13
Augusta 12
Totale 16.236
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 345
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 322
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 243
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 236
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 236
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 224
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 219
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 216
Arecoline tripeptide inhibitors of proteasome 211
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 211
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 206
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 206
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 198
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 196
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 196
Modulation of neutrophil functions by activated platelet release factors 193
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 192
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 190
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 190
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 189
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 187
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 186
Vinyl ester-based cyclic peptide proteasome inhibitors 186
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 185
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 185
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins 184
null 183
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 181
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 180
null 179
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells 179
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 177
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 177
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 175
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 175
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 174
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 173
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 172
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 172
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 170
Attivita' tumoricida dei neutrofili 169
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 168
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 168
null 167
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 166
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 166
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 166
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 165
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 164
A new approach to UV protection by direct surface functionalization of TiO2 with the antioxidant polyphenol dihydroxyphenyl benzimidazole carboxylic acid 164
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 163
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 163
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 160
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 159
ACTION MECHANISM OF ACTIVATORS OF NEUTROPHIL-MEDIATED CYTOTOXICITY 158
ACTIVATED HUMAN FIBROBLASTS ADHERE TO NEUTROPHILS 158
CULTURED HUMAN FIBROBLASTS ACQUIRE ADHESIVENESS FOR NEUTROPHILS AFTER STIMULATION 158
Novel oleanolic vinyl boronates: synthesis and antitumor activity 158
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 158
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells 158
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 157
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress 157
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 157
ANTI-INFLAMMATORY AGENTS INHIBIT NEUTROPHIL CYTOTOXIC ACTIVITY TOWARDS ERYTHROLEUKEMIC HUMAN CELLS 157
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 156
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 153
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 152
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 150
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 144
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 144
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 143
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 142
ACTIVATION OF NEUTROPHIL CYTOTOXICITY BY SYNERGISTIC ACTION OF TPA AND TARGET IMMUNIZATION 139
HLA B51 antigen associated with neutrophil hyper-reactivity 139
Expression and functionality of adenosine receptors in human blood cells 138
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 137
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 135
NEUTROPHIL CR1 RECEPTOR: RELATIONSHIP BETWEEN EXPRESSION LEVEL AND CYTOTOXICITY IN HEALTHY AND CHRONIC MYELOID LEUKEMIA 135
Expression and functional A3 adenosine receptors in human lymphocytes 135
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 135
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 134
Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA 133
Dielectrophoresis (DEP) based Lab-on-a-chip devices for real-time monitoring of the activity of cytotoxic T-lymphocytes. 133
New cyclic peptide proteasome inhibitors 133
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 133
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 133
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 132
Protein kinase C mediates human neutrophil cytotoxicity 132
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 132
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 132
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 131
c-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells 131
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 130
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population 128
Immune escape by Epstein-Barr virus (EBV) carrying burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells 128
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 126
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 126
Intracellular HIV-1 tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1 123
alpha,beta-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells 123
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 123
Totale 16.756
Categoria #
all - tutte 103.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 818
Totale 104.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.387 0 0 0 0 0 213 115 254 73 321 288 123
2021/20221.776 53 158 154 112 93 58 116 96 75 119 151 591
2022/20231.594 168 84 78 215 254 230 84 133 192 10 84 62
2023/2024816 80 126 34 27 50 151 35 61 11 22 17 202
2024/20253.436 82 78 290 162 442 303 64 176 580 339 512 408
2025/20265.731 1.093 344 987 1.212 1.416 679 0 0 0 0 0 0
Totale 23.099